Commercialisation is the process of developing an idea through research to a point where it is ready to be sold in the marketplace.
Taking research to market
Read more about other research and development (R&D) support services available to help businesses and researchers commercialise their products.
Several commercialisation funds help provide a strong investment environment in Queensland for early-stage research and emerging technologies.
The Queensland Government is involved with the bio-venture fund and Medical Research Commercialisation Fund.
In 2010, the Queensland Government committed US$25 million to a new bio-venture fund, which is also supported by global pharmaceutical company Eli Lilly & Co.
Managed by HealthCare Ventures LLC, the fund supports the development and commercialisation of new biotechnology products from across the globe, including research and technology being produced by Queensland's biotechnology industry.
Medical Research Commercialisation Fund
The Queensland Government is involved in the Medical Research Commercialisation Fund, which provides dedicated investment funding to support the commercialisation of early-stage medical research discoveries.
The fund (together with companies, OneVentures, Brandon Capital Partners and HealthCare Ventures) has made one of Australia's largest ever investments in a biotechnology start-up company. Queensland's Vaxxas received $15 million to further develop a revolutionary needle-free vaccine delivery system.